|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 31/4196 | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 47/20 | (2006.01) |
| (11) | Number of the document | 2879661 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13742226.7 |
| Date of filing the European patent application | 2013-07-29 | |
| (97) | Date of publication of the European application | 2015-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-26 |
| (46) | Date of publication of the claims translation | 2022-04-11 |
| (86) | Number | PCT/EP2013/065877 |
| Date | 2013-07-29 |
| (87) | Number | WO 2014/019972 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| 201231271 | 2012-08-03 | ES |
| (72) |
FRANCO RODRÍGUEZ, Guillermo , ES
GUTIERRO ADURIZ, Ibon , ES
|
| (73) |
Laboratorios Farmacéuticos Rovi, S.A. ,
C/ Julián Camarillo 35, 28037 Madrid,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Injekuojamos kompozicijos, kurių sudėtyje yra letrozolo arba anastrozolo |
| INJECTABLE COMPOSITIONS COMPRISING LETROZOLE OR ANASTROZOLE |
| Payment date | Validity (years) | Amount | |
| 2025-07-10 | 13 | 289.00 EUR |
| 2026-07-29 |